Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

BioAtla (BCAB) Equity Average (2020 - 2025)

BioAtla filings provide 6 years of Equity Average readings, the most recent being $2.5 million for Q4 2025.

  • On a quarterly basis, Equity Average fell 86.7% to $2.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.5 million, a 86.7% decrease, with the full-year FY2025 number at $25.2 million, down 40.6% from a year prior.
  • Equity Average hit $2.5 million in Q4 2025 for BioAtla, up from -$24.0 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $220.7 million in Q4 2021 to a low of -$24.0 million in Q3 2025.
  • Median Equity Average over the past 5 years was $125.0 million (2023), compared with a mean of $106.7 million.
  • Biggest five-year swings in Equity Average: surged 407.89% in 2021 and later plummeted 188.3% in 2025.
  • BioAtla's Equity Average stood at $220.7 million in 2021, then fell by 26.84% to $161.5 million in 2022, then tumbled by 48.8% to $82.7 million in 2023, then plummeted by 77.49% to $18.6 million in 2024, then tumbled by 86.7% to $2.5 million in 2025.
  • The last three reported values for Equity Average were $2.5 million (Q4 2025), -$24.0 million (Q3 2025), and -$8.1 million (Q2 2025) per Business Quant data.